TW377352B - Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof - Google Patents

Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof

Info

Publication number
TW377352B
TW377352B TW085113652A TW85113652A TW377352B TW 377352 B TW377352 B TW 377352B TW 085113652 A TW085113652 A TW 085113652A TW 85113652 A TW85113652 A TW 85113652A TW 377352 B TW377352 B TW 377352B
Authority
TW
Taiwan
Prior art keywords
group
lower alkyl
alkyl group
atom
cycloalkyl
Prior art date
Application number
TW085113652A
Other languages
English (en)
Inventor
Kazuhisa Takayama
Hiroyuki Hisamichi
Masahiro Iwata
Hideki Kubota
Motonori Aoki
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of TW377352B publication Critical patent/TW377352B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW085113652A 1995-11-21 1996-11-08 Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof TW377352B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP30306595 1995-11-21
JP772596 1996-01-19
JP4385396 1996-02-29
JP14186896 1996-06-04

Publications (1)

Publication Number Publication Date
TW377352B true TW377352B (en) 1999-12-21

Family

ID=27454776

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085113652A TW377352B (en) 1995-11-21 1996-11-08 Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof

Country Status (12)

Country Link
US (1) US6136810A (zh)
EP (1) EP0885894A4 (zh)
JP (1) JP3110765B2 (zh)
KR (1) KR19990071520A (zh)
CN (1) CN1202171A (zh)
AU (1) AU705039B2 (zh)
BR (1) BR9611628A (zh)
CA (1) CA2236683A1 (zh)
HU (1) HUP9900607A3 (zh)
NZ (1) NZ322197A (zh)
TW (1) TW377352B (zh)
WO (1) WO1997019078A1 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417190B1 (en) * 1998-12-17 2002-07-09 Boehringer Ingelheim Pharma Kg Tricyclic nitrogen heterocycles as PDE IV inhibitors
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
JP2003529561A (ja) * 2000-02-08 2003-10-07 ワックス、マーティン、ビー 緑内障の治療法
US6413968B1 (en) * 2000-06-30 2002-07-02 O'donnell, Jr. Francis E. Treatment of myasthenia gravis by cyclic nucleotide phosphodiesterase inhibition
AU2002224417A1 (en) * 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders
ME00549B (me) * 2001-01-29 2011-10-10 Serono Lab Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
EP1364950A4 (en) * 2001-02-26 2005-03-09 Tanabe Seiyaku Co PYRIDOPYRIMIDINE OR NAPHTHYRIDINE DERIVATIVE
EP1450837A4 (en) * 2001-08-07 2006-01-04 Immunex Corp INTERLEUKIN-1 RECEPTORS IN THE TREATMENT OF DISEASES
KR100490970B1 (ko) * 2002-03-22 2005-05-24 씨제이 주식회사 신규 피리도[2,3-ｄ]피리미딘 카르보알데히드 옥심계ＰＤＥ Ⅳ 효소 저해 화합물 및 이의 제조방법
PL1685849T3 (pl) 2003-11-20 2012-07-31 Astellas Pharma Inc Inhibitory PDE 4 do leczenia śródmiąższowego zapalenia pęcherza moczowego
PE20070823A1 (es) * 2005-11-15 2007-08-09 Glaxo Group Ltd Sal tosilato de 8-(2,6-difluorofenil)-4-(4-fluoro-2-metilfenil)-2-{[2-hidroxi-1-(hidroximetil)etil]amino}pirido[2,3-]pirimidin-7(8h)-ona
US7750019B2 (en) 2006-08-11 2010-07-06 Kowa Company, Ltd. Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
NZ578744A (en) * 2007-01-31 2012-02-24 Vertex Pharma 2-aminopyridine derivatives useful as kinase inhibitors
US7790737B2 (en) 2007-03-13 2010-09-07 Kowa Company, Ltd. Substituted pyrimidine compounds and their utility as CETP inhibitors
EP2292089A1 (en) 2008-01-11 2011-03-09 Astellas Pharma Inc. Model animal having both pain in testis or testis-related discomfort actions and frequent urination
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
CA2731451A1 (en) 2008-07-23 2010-01-28 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
JP5631310B2 (ja) 2008-07-23 2014-11-26 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 三環式ピラゾロピリジンキナーゼ阻害剤
AU2009279611A1 (en) 2008-08-06 2010-02-11 Vertex Pharmaceuticals Incorporated Aminopyridine kinase inhibitors
AU2010245914A1 (en) 2009-05-06 2011-12-15 Vertex Pharmaceuticals Incorporated Pyrazolopyridines
CA2787363A1 (en) 2010-01-27 2011-08-04 Vertex Pharmaceuticals Incorporated Pyrazolopyrimidine kinase inhibitors
EP2528917B1 (en) 2010-01-27 2016-10-19 Vertex Pharmaceuticals Incorporated Pyrazolopyridines useful for the treatment of autoimmune, inflammatory or (hyper)proliferative diseases
CA2787079A1 (en) 2010-01-27 2011-08-04 Vertex Pharmaceuticals Incorporated Pyrazolopyrazine kinase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA932731A (en) * 1968-12-10 1973-08-28 E. Hardtmann Goetz 1,2-dihydro-pyrido(2,3-d)pyrimidin-2-ones
BE757702A (fr) * 1969-10-20 1971-04-19 Sandoz Sa Derives de la pyrido (2,3-d) pyrimidine, leur preparation et medicaments les contenant.
US3709888A (en) * 1970-06-01 1973-01-09 Sandoz Ag Aryl-substituted-pyrido(2,3-d)pyrimidin-2-ones
US3853898A (en) * 1971-07-20 1974-12-10 Sandoz Ag 3-(2-substituted amino) pyridyl-phenyl ketone imines
US3758475A (en) * 1971-07-20 1973-09-11 Sandoz Ag Pyrido(2,3-d)pyrimidin 2 ones
JPS5394040A (en) * 1976-12-06 1978-08-17 Sandoz Ag Coagolation controlling agent for blood platelet
US4224328A (en) * 1979-04-11 1980-09-23 Sandoz, Inc. Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors
MX7829A (es) * 1986-08-21 1993-08-01 Pfizer Quinazolindionas y piridopirimindionas y procedimiento para su preparacion
US5264437A (en) * 1992-03-20 1993-11-23 Syntex (U.S.A.) Inc. Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
TW299333B (zh) * 1992-12-29 1997-03-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
HUP9900607A2 (hu) 1999-06-28
US6136810A (en) 2000-10-24
CA2236683A1 (en) 1997-05-29
NZ322197A (en) 1999-02-25
CN1202171A (zh) 1998-12-16
HUP9900607A3 (en) 1999-11-29
EP0885894A4 (en) 2000-01-19
JP3110765B2 (ja) 2000-11-20
KR19990071520A (ko) 1999-09-27
WO1997019078A1 (en) 1997-05-29
EP0885894A1 (en) 1998-12-23
AU7588696A (en) 1997-06-11
AU705039B2 (en) 1999-05-13
BR9611628A (pt) 1999-06-01

Similar Documents

Publication Publication Date Title
TW377352B (en) Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
NO903438L (no) Fremgangsmaate for fremstilling av tiazolderivater.
HUT40798A (en) Process for producing new, heterocyclic imidazol derivatives and pharmaceutically acceptable acid additional salts thereof
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
NO882608L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridiner.
FI913446A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä
HUT77225A (hu) Kondenzált izoxazol-oxi- és -tio-alkil-amin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUT68856A (en) Acridine derivatives, pharmaceutical compositions comprising the same compouds as effective substances and a process for producing the compounds and the pharmaceutical compositions
IE872650L (en) Imidazopyridine derivatives, their production, and¹pharmaceutical compositions containing them
NO922512D0 (no) Tetrahydropyrrolo(1,2-a)pyrazin-4-spiro-3'-pyrrolidinderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater inneholdende slike
HU900636D0 (en) Process for preparation of new tetrahydro-benzimidazole derivatives and pharmaceutical compositions containing the above compounds
NZ232283A (en) Substituted imidazo(1,2-b)pyridazine derivatives; pharmaceutical compositions and preparatory processes
ATE81655T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
BG105855A (en) 2-aminopyridines containing fused ring substituents
EP1219605A4 (en) UREA COMPOUNDS, PROCESS FOR PRODUCING AND USING THE SAME
EP0974589A4 (en) BENZIMIDAZOLES DERIVATIVES AND SALTS THEREOF PHARMACEUTICALLY ACCEPTABLE
AU4458793A (en) Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors
RU98111593A (ru) Производные пиридо[2,3-]пиримидина и их фармацевтические композиции
PL304334A1 (en) Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract